December 28, 2023
December we’ve been present at three important events in the USA, Belgium and Türkiye. Furthermore, although we already started started preparations throughout 2023, […]
November 28, 2023
n November we’ve been present at two important conferences in the USA and England. Furthermore, we’ve been meeting our distribution partner from […]
October 28, 2023
In October we’ve been (re)presented at three important local conferences: n collaboration with our distributor Auxilto, DEBx Medical was present during the 3-day […]
September 28, 2023
During September we’ve been present at three important local conferences:
September 19, 2023
Our valued distributor Berner Medical, is introducing our novel debriding agent, DEBRICHEM®, at the Sårbehandlingssymposium in Sollentuna, Stockholm. If you’re at […]
September 4, 2023
We are thrilled to share that we are getting ready to attend a series of upcoming conferences worldwide. These events […]
August 28, 2023
In August, we’ve been present at two important local conferences in Bangkok, Thailand: The Thai Venous Forum Basic Course and […]
June 22, 2023
Our novel debriding agent, DEBRICHEM®, has recently been featured in a 3 article supplement in the Journal of Wound Care. […]
May 22, 2023
TVM Capital Healthcare Announces Euro 10 Million Investment in DEBx Medical DEBx Medical is innovating the management of chronic wounds, […]
February 24, 2023
We are excited to announce that our latest paper, “Combining an Acidic Compound and NPWT: Debridement and Granulation in Leg […]
November 1, 2022
A new peer-reviewed paper on our novel debriding agent DEBRICHEM® was published in the October edition of the Journal of […]
October 25, 2022
At the end of this week, DEBx Medical will participate in the Commonwealth and 4th Global Wound Conference at the […]
October 20, 2022
Today marks the 2nd annual International Stop Wound Infection Day. This day is about raising awareness of effective identification, prevention […]
September 7, 2022
Now that the summer holidays are coming to an end and everyone is getting back to work, the focus shifts […]
June 13, 2022
Rotterdam, The Netherlands, June 13, 2022 – DEBx Medical, the Dutch medical technology company revolutionizing the management of chronic wounds, […]
May 19, 2022
We are delighted to be attending the joint EWMA & Journées Cicatrisations Conference on 23-25 May 2022 in Paris next […]
March 2, 2022
This week we will be presenting our novel debridement agent that addresses the biofilm in chronic wounds during the World […]
January 25, 2022
Despite the best intentions for bringing together the international wound community in Paris, it has become clear that the most […]
December 15, 2021
Healthcare systems have been severely impacted by the COVID-19 pandemic, both in terms of workload and the resources, what has impacted […]
September 28, 2021
Rotterdam, The Netherlands, September 28, 2021 – DEBx Medical, the Dutch medical technology company revolutionizing the management of chronic wounds, […]
September 22, 2021
DEBx Medical is excited to present a special Biofilm session at the Polish 2nd Online Wound Treatment conference with Prof […]
September 15, 2021
DEBx Medical is attending the meeting of Soceidade Portuguesa de Cirurgia Plástica Reconstrutiva e Estetica, at Pestana Palace in Lisbon. Bert Quint, […]
August 20, 2021
About DEBx Medical My name is Bert Quint, I am the CEO and co-founder of DEBx Medical. In support of […]
August 3, 2021
Our partner, the National Biofilms Innovation Centre, announced that the first-ever awareness week dedicated to celebrating all things related to […]
June 16, 2021
In our last article, we wrote about the impact of the COVID-19 pandemic on wound care and indicated how the […]
May 5, 2021
The impact of the ongoing pandemic on the overall healthcare systems is becoming more and more evident. COVID-19 is highly […]
April 15, 2021
This Thursday and Friday, DEBx Medical will be a virtual participant in the online edition of the Innovation for Health […]
April 6, 2021
DEBRICHEM is a disruptive new treatment option to address the infection in hard to heal wounds. The topical gel offers […]
March 26, 2021
Last Friday, a new article about DEBx Medical and our product DEBRICHEM was published online on Bioworld Medtech. The article […]
March 19, 2021
Rotterdam, The Netherlands, March 19, 2021 – In early February, we finally obtained our ISO 13485:2016 certificate and our CE-certificate for DEBRICHEM. DEBRICHEM is […]
February 25, 2021
Rotterdam, The Netherlands, February 25, 2021 – DEBx Medical, the Dutch medical technology company revolutionizing the management of chronic wounds, […]
February 16, 2021
Rotterdam, The Netherlands, February 16, 2021 – DEBx Medical, the Dutch medical technology company revolutionizing the management of chronic wounds, […]
October 28, 2020
We are happy to announce that DEBx Medical has joined the network of the National Biofilm Innovation Centre (NBIC) of […]
October 20, 2020
Exiting things are happening at DEBx Medical, and we want to share some important news with you. We are proud […]
October 6, 2020
In these times of fewer conventions, congresses, and scientific meetings the world is luckily still continuing scientific research and publishing […]
October 1, 2020
At the South Western Sydney LHD, part of the Ingham Institute of applied medical research, Professor Matthew Malone has performed […]
August 28, 2020
In these times of confinement and quarantine due to the COVID-19 virus, the care for chronic wounds has become somewhat […]
August 5, 2020
After DEBx Medical took the first steps in its development in Amsterdam last year, our head office moved from the […]
July 31, 2020
DEBx Medical had planned to attend the following wound care conferences: the WUWHS in Abu Dhabi and the EWMA in […]
January 16, 2020
DEBx Medical will be participating at the Medical Congress EWMA2020 From May 13 – 15, 2020 Visit www.ewma.org for more […]
January 16, 2020
We will be participating at the Medical Congress WUWHS2020 From March 8 – 12, 2020Visit us at H5 – stand […]
